MDXG - MiMedx Group, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
4.3400
+0.1400 (+3.33%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close4.2000
Open4.1900
Bid0.0000 x 1000
Ask0.0000 x 800
Day's Range4.1900 - 4.5000
52 Week Range0.9500 - 8.1800
Volume1,826,577
Avg. Volume666,006
Market Cap472.314M
Beta (3Y Monthly)1.18
PE Ratio (TTM)13.95
EPS (TTM)0.3110
Earnings DateFeb 23, 2018 - Mar 5, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est18.00
Trade prices are not sourced from all markets
  • Business Wire9 days ago

    Shareholder Group Comments on MiMedx Shareholder Meeting

    The MiMedx Shareholder Group (Petit, George, Furstenberg) wants to thank all of our shareholders that voted for our slate at the 2018 annual meeting that was held today. This means that there will probably not be a 2019 shareholder meeting held on August 19th or sooner. Also, the Board will be able to make further changes in the bylaws to further thwart shareholders exercising their rights.

  • PR Newswire9 days ago

    MiMedx Shareholders Overwhelmingly Support Election of All Three of MiMedx's Highly Qualified Director Nominees

    Preliminary Vote Count Indicates that MiMedx's Director Nominees Received Support from Approximately 80% of the Votes Cast MiMedx Shareholders Reject Petit Group's Proposal to Hold 2019 Meeting in August ...

  • Business Wire10 days ago

    MiMedx Continues to Fight against Holding 2019 Annual Meeting

    Hialeah Municipal Fund, a MiMedx shareholder, filed a lawsuit April 18, 2019, to force the Company to hold the 2019 Annual Meeting for the election of three Class III directors on June 17, 2019, at the same time as the Court ordered the Company to hold the 2018 Annual Meeting. Just as MiMedx did in opposing the first Hialeah lawsuit regarding the 2018 Annual Meeting for the election of three Class II directors, they are refusing to agree on a date to hold the 2019 Annual Meeting. The Company filed a Notice of Hearing for its Motion to Dismiss the second Hialeah lawsuit in the Circuit Court of Leon County, Florida on June 11, 2019.

  • Business Wire12 days ago

    Former Chairman and CEO "Pete" Petit Highlights Flaws in Revenue Recognition Allegations

    All the revenue recognition allegations against MiMedx purposefully ignore the stark reality that the Company collected basically all of its booked revenue over the years. In addition, the Company bought over $130 million of its stock back without incurring debt or affecting revenue and profit growth.

  • PR Newswire12 days ago

    MiMedx Urges Shareholders to Vote Today "FOR" All of the Board's Highly Qualified Nominees on the BLUE Proxy Card

    MARIETTA, Ga., June 14, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, encourages shareholders to vote "FOR" all of the Board's highly qualified nominees online or by telephone by following the easy instructions on the BLUE Proxy Card. The 2018 Annual Meeting of Shareholders (the "Annual Meeting") will be held on Monday, June 17, 2019 – shareholders are urged to vote the BLUE proxy card TODAY.

  • PR Newswire13 days ago

    MiMedx Highlights Skills and Experience of Director Nominees

    Company Urges Shareholders to Vote with the BLUE Card Online or By Phone Today MARIETTA, Ga. , June 13, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), ...

  • PR Newswire14 days ago

    Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS and Egan-Jones in Recommending MiMedx Shareholders Vote "For" All Three of the Company's Director Nominees

    MARIETTA, Ga., June 12, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced that leading independent proxy advisory firm Glass, Lewis & Co. ("Glass Lewis") has joined Institutional Shareholder Services ("ISS") and Egan-Jones Proxy Services ("Egan-Jones") in recommending MiMedx shareholders vote "FOR" the Company's three director nominees – K. Todd Newton, Dr. Kathleen Behrens Wilsey and Timothy R. Wright – on the BLUE proxy card in connection with the Company's 2018 Annual Meeting of Shareholders to be held on June 17, 2019.

  • PR Newswire15 days ago

    MiMedx Secures $75 million Non-Dilutive Debt Financing

    Completes Key Milestone in Execution of Company's Long-Range Strategic Plan MARIETTA, Ga. , June 11, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), ...

  • PR Newswire15 days ago

    Leading Independent Proxy Advisory Firms ISS and Egan-Jones Recommend That MiMedx Shareholders Vote the BLUE Card "FOR" All Three of the Company's Director Nominees

    ISS Recommends Shareholders Vote "AGAINST" the Petit Group's Shareholder Proposals ISS Recommends Shareholders Do Not Vote the White Card MARIETTA, Ga. , June 11, 2019 /PRNewswire/ -- MiMedx ...

  • Business Wire16 days ago

    Mimedx Shareholder Group Urges Shareholders to Vote on the White Proxy Card for the 2018 Annual Meeting of Mimedx Group, Inc. on June 17, 2019

    IT IS ONLY BY A COMBINATION OF THESE TWO OVERDUE BOARD ELECTIONS THAT YOU, THE SHAREHOLDER, WILL HAVE THE RIGHT TO VOTE ON THE MAJORITY OF THE BOARD OF YOUR COMPANY. We TRUST YOU to know the Company DID NOT WANT YOU TO HAVE THIS RIGHT TO CHANGE CONTROL NOW. Whether by their actions in the Courts in Florida, or by delaying for at least six months a request of the SEC to grant an exemption to hold the 2018 meeting, the Company has done and continues to do everything in its power to DELAY AND DENY YOU THIS RIGHT.

  • PR Newswire16 days ago

    MiMedx Issues Additional Information to Shareholders

    MARIETTA, Ga., June 10, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today issued additional information to shareholders regarding the Company's upcoming 2018 annual meeting of shareholders (the "Annual Meeting"), scheduled to be held on June 17, 2019 at 9:00 a.m. local time, at the Marietta Conference Center (Hilton Atlanta/Marietta) at 500 Powder Springs St., Marietta, GA 30064.

  • PR Newswire19 days ago

    MiMedx Urges Shareholders to Vote "FOR" All of the Board's Qualified Nominees on the BLUE Proxy Card

    MARIETTA, Ga., June 7, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, is sending a new mailing to shareholders highlighting the experience of its three new highly qualified nominees standing for election to the Board of Directors (the "Board") at the 2018 annual meeting of shareholders scheduled for June 17, 2019, and calling on shareholders to vote the Company's BLUE proxy card.

  • PR Newswire21 days ago

    MiMedx Issues New Presentation for Investors in Advance of 2018 Annual Meeting

    MARIETTA, Ga., June 5, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today released an investor presentation summarizing the reasons why the Company believes shareholders should support the Company's three nominees for the Board of Directors (the "Board") at the 2018 annual meeting of shareholders that will take place on June 17, 2019.

  • PR Newswire22 days ago

    MiMedx Shareholders Should Visit www.VoteBlueForMiMedx.com

    MARIETTA, Ga., June 4, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today encouraged shareholders to visit its new campaign website, www.VoteBlueForMiMedx.com. MiMedx launched the website in connection with the upcoming 2018 annual meeting of shareholders ("Annual Meeting"). An overview of the comprehensive board refreshment plan announced on May 30, 2019 and the highly qualified and experienced MiMedx nominees who are up for election at the Annual Meeting.

  • PR Newswire23 days ago

    MiMedx Files Definitive Proxy Materials and Mails Letter to Shareholders

    MARIETTA, Ga., June 3, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced that it has filed definitive proxy materials with the U.S. Securities and Exchange Commission ("SEC") in connection with its upcoming 2018 annual meeting of shareholders ("Annual Meeting") scheduled to be held on June 17, 2019 at 9:00 a.m. local time, at the Marietta Conference Center (Hilton Atlanta/Marietta) at 500 Powder Springs St., Marietta, GA 30064. The Company has nominated to the board of directors of the Company (the "Board") three experienced healthcare professionals, none of whom has served on the MiMedx Board previously. Two of these candidates were identified by one of the Company's largest shareholders, Prescience Point Capital Management LLC (together with its affiliates, "Prescience Point"), and the third candidate is our new Chief Executive Officer.

  • Barrons.com25 days ago

    Bed Bath & Beyond, Piece by Piece

    13Ds are filed with the Securities and Exchange Commission within 10 days of an entity’s attaining a greater than 5% position in any class of a company’s securities. Privet has now followed with a letter addressed to the board reaffirming that offer. Also in the letter, Privet “urged [Synalloy] not to take any action to change its current capitalization” before thoroughly reviewing the proposal.

  • Here's Why Shares of MiMedx Group Jumped Higher Today
    Motley Fool27 days ago

    Here's Why Shares of MiMedx Group Jumped Higher Today

    A new board could signify the start of a turnaround.

  • PR Newswire27 days ago

    MiMedx Announces Comprehensive Board Refreshment Plan in Cooperation with Prescience Point

    MARIETTA, Ga., May 30, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced that the Company's board of directors (the "Board") has adopted a comprehensive plan to refresh the composition of the Board. The plan was developed by the Board in cooperation with one of the Company's largest shareholders, Prescience Point Capital Management LLC ("Prescience Point"), and follows the completion of the Audit Committee's independent investigation into alleged wrongdoing by the prior senior management team and the engagement of BDO USA, LLP as the Company's new independent registered public accounting firm.

  • PR Newswire29 days ago

    MiMedx Announces BDO as the Company's New Independent Registered Public Accounting Firm

    MARIETTA, Ga., May 28, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced that the Audit Committee of the Company's Board of Directors approved the engagement of BDO USA, LLP ("BDO") as the Company's new independent registered public accounting firm. BDO delivers assurance and tax advisory services to clients throughout the country and around the globe, and is the 5th largest firm in the world serving publicly traded domestic and international clients. "We are extremely pleased to welcome BDO as MiMedx's new independent auditor," said Edward J. Borkowski, MiMedx's interim Chief Financial Officer.

  • Benzingalast month

    WSJ: MiMedx Injectables Flout FDA Regulations

    MiMedx Group Inc (OTC: MDXG) can't seem to leave controversy behind. MiMedx, which sells injectable wound care products, was testing the finished products quarterly as opposed to checking each lot, WSJ said, citing an internal document prepared for the company in January by Lachman Consultants. The biomedical product company sells wound care products derived from the amniotic sac that protects the fetus, processing it into patches or grinding it into a powder.

  • Benzingalast month

    The Daily Biotech Pulse: FDA Nod For Novocure, Dynavax Restructures, Therapix Receives Nasdaq Notice

    The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs May 23.) ArQule, Inc. (NASDAQ: ARQL ) Turning Point ...

  • MarketWatchlast month

    MiMedx probe finds execs spied on potential whistleblowers with secret video

    MiMedx Group Inc. said late Thursday an internal investigation revealed that now-former executives spied on employees to discredit whistleblowers. The wound-care products company's stock was delisted from the Nasdaq in November after the company's chief executive and chief operating officer resigned in July during an internal audit. Late Thursday, the company said the audit uncovered 2,750 hours of video footage from a secret surveillance system installed under orders of Parker Petit, the company's former chairman and CEO. The audit found that Petit, former COO William Taylor, former Chief Financial Officer Michael Senken, and former Controller John Cranston knew about revenue manipulation practices related to deals with its largest distributor. The company also said Petit and Taylor launched an internal investigation named "Project Snow White," which included secret surveillance, to root out potential whistleblowers and employees who were concerned about the company's practices.

  • PR Newswirelast month

    MiMedx Announces Conclusion of Audit Committee's Independent Investigation

    MARIETTA, Ga., May 23, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or "the Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced that the Audit Committee of the Board of Directors has concluded its independent investigation ("the Investigation") into matters relating to, among other things, allegations regarding certain sales and distribution practices at the Company. As announced on February 20, 2018, the Audit Committee retained King & Spalding LLP as counsel to assist the Audit Committee in conducting its Investigation.

  • Barrons.com2 months ago

    Activist Raging Capital Sizes Up Tidewater

    Prescience Point Capital Management cut its holding of the regenerative biomaterials maker to 7,618,335 shares on April 29 through May 3. During that span, Prescience acquired 250,000 shares for $2.31 to $2.51 each and sold 603,925 at prices ranging from $2.44 to $2.53 apiece. Prescience now owns nearly 7% of MiMedx’s outstanding stock.